abstract |
The present invention relates to a membrane bound form of ST2 protein known as ST2L protein, particularly the development of reagents such as antibodies, ligands, agonists and/or antagonists specific for ST2L which may be used in cell separation or identification, drug screening and treatment of ailments such as infections, inflammation, and allergy. |